National Center for Complementary and Integrative Health (NCCIH)
Georgetown University
Age
18–64
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Age ≥ 18 years
BMI ≥ 18.5 kg/m2
Self-identify as non-Hispanic African American or non-Hispanic European American
Ability and willingness to transport for regular clinic visits.
Ability and willingness to swallow study capsules.
Willingness to refrain from intentional weight loss
Willingness maintain usual physical activity levels and dietary intake throughout the trial.
You may not be if
Age \> 65 years
BMI ≥ 40 kg/m2
Currently pregnant or breastfeeding.
Currently receiving treatment for cancer (excluding adjuvant therapies).
Consumption of DHA/EPA-rich fish 2 or more days a week (defined as \>0.5 g DHA or EPA/serving)
Has a history of atrial fibrillation.
Has been diagnosed with a significant psychiatric condition that might compromise adherence to study protocols, including eating disorders, schizophrenia, bipolar (manic phase), severe personality disorders, severe major depressive, severe anxiety disorders, and substance use disorders.
Have an allergy to the study oils.
Have received other investigational agents within the past 6 months.
Currently on a weight reducing diet or has lost \>5% body weight in the past 6 months.
Currently using GLP-1
Currently using prescribed anticoagulants or have a blood clotting problem or disease that causes excessive bleeding or been told by a physician that you have an increased risk of serious bleeding
Currently using oral steroids
Perceivably unable or unwilling to use acetaminophen in place of aspirin (including low dose regimen), NSAIDS, or other COX-2 inhibitors.
Perceivably unable or unwilling to refrain from using anti- inflammatory supplements (including n-3 supplements).
Perceivably unable or unwilling to refrain from using montelukast-type of allergy medications.
Run-in failure
Clareo Health | Omega-3D: Omega-3 for Diet-Driven Health Disparities
